{
    "organizations": [],
    "uuid": "0a6d2f45a8c042dae336fcf6055b2396bca2407c",
    "author": "",
    "url": "https://www.reuters.com/article/brief-gsk-ceo-says-no-expected-dividend/brief-gsk-ceo-says-no-expected-dividend-increase-in-near-term-idUSL1N1P41B9",
    "ord_in_thread": 0,
    "title": "BRIEF-GSK CEO Says No Expected Dividend Increase In Near Term",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 9 (Reuters) - Glaxosmithkline Plc:\n* GSK CEO SAYS WILL TAKE TIME TO BUILD REIMBURSEMENT FOR SHINGRIX SHINGLES VACCINE\n* GSK CEO SAYS HAS NO DOUBT SHINGRIX CAN BE COMPANY‘S MOST LUCRATIVE VACCINE\n* GSK CEO SAYS NO CHANGE TO DIVIDEND POLICY LAID OUT LAST YEAR\n* GSK CEO SAYS NO EXPECTED DIVIDEND INCREASE IN NEAR TERM * GSK CEO SAYS HAVING A LOOK AT PFIZER CONSUMER BUSINESS; WE DON‘T NEED IT, WOULDN‘T OVERPAY FOR IT Source text for Eikon: Further company coverage: (Reporting By Bill Berkrot)\n ",
    "published": "2018-01-09T21:26:00.000+02:00",
    "crawled": "2018-01-09T21:43:15.000+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "glaxosmithkline",
        "plc",
        "gsk",
        "ceo",
        "say",
        "take",
        "time",
        "build",
        "reimbursement",
        "shingrix",
        "shingle",
        "vaccine",
        "gsk",
        "ceo",
        "say",
        "doubt",
        "shingrix",
        "company",
        "lucrative",
        "vaccine",
        "gsk",
        "ceo",
        "say",
        "change",
        "dividend",
        "policy",
        "laid",
        "last",
        "year",
        "gsk",
        "ceo",
        "say",
        "expected",
        "dividend",
        "increase",
        "near",
        "term",
        "gsk",
        "ceo",
        "say",
        "look",
        "pfizer",
        "consumer",
        "business",
        "need",
        "overpay",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "reporting",
        "bill",
        "berkrot"
    ]
}